| First Author | Xie Y | Year | 2024 |
| Journal | Cancer Lett | Volume | 582 |
| Pages | 216567 | PubMed ID | 38070822 |
| Mgi Jnum | J:343870 | Mgi Id | MGI:7569962 |
| Doi | 10.1016/j.canlet.2023.216567 | Citation | Xie Y, et al. (2023) EphB1 promotes the differentiation and maturation of dendritic cells in non-small cell lung cancer. Cancer Lett 582:216567 |
| abstractText | EphB1 is implicated in numerous physiological and pathological processes, including nervous system diseases, cardiovascular diseases and cancers. It binds to membrane-bound ligands and drives bidirectional signaling. EphB1, along with its ligand ehrinB, plays a pivotal role in activating immune cells. However, despite its presence in dendritic cells (DCs), EphB1's involvement in the differentiation and maturation of DCs in cancers remains inadequately understood. In this study, we found compromised differentiation and maturation of DCs in EphB1(-/-) mice bearing lung adenocarcinoma syngeneic tumors. Our in vitro assays revealed that EphB1 phosphorylation induced DC differentiation and maturation. Cox-2, a key enzyme involved in the production of proinflammatory molecules, is implicated in DC differentiation induced by phosphorylated EphB1. Additionally, the study has identified lead compounds that specifically target EphB1 phosphorylation sites. Collectively, this research on EphB1 phosphorylation has provided valuable insights into the regulation of immune cell functionality and holds the potential for the development of innovative therapeutic strategies for a range of diseases. |
